CTSA Program Posters

  • Regenstrief Institute

    The Covid-19 Research Data Commons (CoRDaCo) aims to create an efficient and effective way of quickly generating datasets for Covid-19 related research. CoRDaCo integrates multiple sources of clinical and social determinants data into one central repository, which can be leveraged for many uses. Creating a curated collection of data elements specific to Covid-positive patients and stored in a

  • University Of Chicago
    The pandemic put a stop to many things: big launch events, in-person gatherings, and other ways to spread information and recruit for clinical trials in the physical world. So we went digital. Social listening data showed mental health was being talked about just as much as COVID-19, and this paired with a boom in pet adoptions while everyone was stuck at home. The wave of new fur children sparked
  • University at Buffalo CTSI Translational Imaging Core Poster
    State University Of New York At Buffalo

    The CTSI Translational Imaging Core supports pre-clinical and clinical imaging, which is a particular strength of researchers in the Buffalo Translational Consortium (BTC). Establishing the Imaging Core in 2015, supported by the CTSA, has enabled us to markedly expand our user base, supporting 102 peer-reviewed publications, 71 funded grants and an additional 77 submitted grants. In addition to

  • BIOS and Catalyst Programs: Accelerating UCSF Research to Improve Health
    University Of California San Francisco
    Both Biospecimen Precision Medicine Research (BIOS) Program and Catalyst Program, the current UCSF Clinical and Translational Science Institute’s (CTSI) optional cores, provide much needed services and infrastructure to conduct clinical translational research. The BIOS Program has developed a repository of high-quality human biospecimens for world-class research and precision medicine efforts. The
  • Icahn School Of Medicine At Mount Sinai

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the resulting coronavirus disease 2019 (COVID-19) have stretched healthcare systems thin across the world. During a COVID-19 surge, local academic medical centers must both care for the ill and perform research to better understand the pathogenicity of this disease. Here, we provide an account of a 49-day period during which we built

  • University Of North Carolina Chapel Hill

    True innovation depends on identifying the right problem to solve. To streamline the process of identifying opportunities for innovation, FastTraCS has developed a virtual, scalable approach to rapidly identifying impactful clinical problems—creating a foundation for unmet need definition, validation and new product development. This approach eliminates the need for upfront clinical shadowing/

  • Wake Forest CTSI Nonhuman Primate Signature Program
    Wake Forest University Health Sciences

    Kylie Kavanagh, Matthew J. Jorgensen, J. Mark Cline, D. McClain The goal of Wake Forest (WF) Nonhuman Primate (NHP) Signature Program is to accelerate translational research by providing access to the ultimate translational animal model. NHP have served as an extremely successful preclinical platform that has allowed the bidirectional flow of knowledge from scientists to clinicians and back to

  • Pennsylvania State Univ Hershey Med Ctr

    Penn State Clinical and Translational Science Institute has led University-wide efforts to transform clinical and translational science since 2007. It promotes interdisciplinary collaboration and provides essential research infrastructure. This research infrastructure allows Penn State to quickly address and adjust to current events, high priority translational research topics and, most recently

  • University Of New Mexico Health Scis Ctr

    Objective: The SARS-COV-2 pandemic resulted in a shutdown of most in-person clinical research as social quarantine measures were implemented. To inform start up procedures for research related to substance use disorders (SUD) we held a Roundtable event with clinicians who remained in practice during the quarantine. The Roundtable aimed to bring perspectives from multiple specialties on how

  • Washington University

    Introduction: The STOP COVID Trials were innovative fully-remote randomized controlled trials of fluvoxamine (a sigma1 receptor agonist with anti-inflammatory properties) vs placebo for treatment of outpatients with early COVID-19 who were self-isolating at home. Methods: The trials used eConsent and an electronic data capture system with integrated recruitment from the EPIC electronic health